Ryman Healthcare EBITDA 2024-2025 | RYHTY

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Ryman Healthcare ebitda from 2024 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Ryman Healthcare ebitda from 2024 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.

Related Stocks
Company Name	Market Cap
Danaher (DHR)	$145.3B
CVS Health (CVS)	$75.4B
Elevance Health (ELV)	$64.4B
Cencora (COR)	$55.5B
DiDi Global (DIDIY)	$26B
Labcorp Holdings (LH)	$21.9B
Natera (NTRA)	$18.8B
BioMerieux (BMXMF)	$17.1B
ICON (ICLR)	$15.3B
EUROFINS SCIENT (ERFSF)	$14.9B
CochLear (CHEOY)	$13.4B
Solventum (SOLV)	$12.8B
Medpace Holdings (MEDP)	$12.7B
Revvity (RVTY)	$11.2B
Viatris (VTRS)	$10.9B
Avantor (AVTR)	$9.5B
Sonic Healthcare (SKHHY)	$9.2B
Charles River Laboratories (CRL)	$8.8B
HealthEquity (HQY)	$8.3B
Caris Life Sciences,�Inc (CAI)	$6.9B
Amplifon S.p.A (AMFPF)	$5.4B
Bausch + Lomb (BLCO)	$5.1B
BrightSpring Health Services (BTSG)	$3.6B
Sotera Health (SHC)	$3.5B
Surgery Partners (SGRY)	$2.9B
Organon (OGN)	$2.6B
Concentras Parent (CON)	$2.6B
GeneDx Holdings (WGS)	$2.4B
Alignment Healthcare (ALHC)	$2.3B
Progyny (PGNY)	$2B